Online citations, reference lists, and bibliographies.
← Back to Search

Apoptosis In Hormone-responsive Malignancies.

S. Denmeade, D. McCloskey, I. B. Joseph, H. A. Hahm, J. Isaacs, N. Davidson
Published 1997 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Publisher Summary The breast and prostate cancer belong to the spectrum of hormone-related malignancies. So, this chapter seeks to review current knowledge about the role of programmed cell death in the normal development and function of the mammary and prostate glands, the carcinogenic process, and the prevention and therapy of breast and prostate cancers. Its suitability as a target for new therapies for both cancers is also explored. Although the focus of the chapter is on breast and prostate cancers, it seems likely that lessons learned from these two neoplasms is also of relevant to a variety of other epithelial malignancies. Breast and prostate represent two excellent model tissues in which to study the balance between cell proliferation and cell death in the normal setting. Research suggests that steroid hormones are key factors that promote proliferation and block death in both tissues. In addition, the pivotal role of programmed cell death in the normal lactational cycle of the breast has been identified. Furthermore, hormone-responsive breast and prostate cancers retain a similar programmed cell death pathway(s) that can be triggered by hormone withdrawal. Similar or identical pathways also exist in endocrine-unresponsive prostate and breast cancer cells even though hormonal manipulation is no longer capable of triggering these pathways. As the components of these pathways, their activators, and their inhibitors are delineated, these programmed cell death pathways provide opportunities for the development of new therapeutic approaches.
This paper references
10.1210/MEND-1-12-865
Androgen regulation of c-myc messenger ribonucleic acid levels in rat ventral prostate.
V. Quarmby (1987)
Induction of programmed cell death in human breast cancer cells by an unsymmetrically alkylated polyamine analogue.
D. McCloskey (1995)
10.1083/JCB.119.3.493
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
Y. Gavrieli (1992)
10.1016/0006-291X(89)91035-8
"Thymineless" death in androgen-independent prostatic cancer cells.
N. Kyprianou (1989)
10.1016/0014-4827(91)90380-D
Spermine prevents endonuclease activation and apoptosis in thymocytes.
B. Brüne (1991)
10.1016/0167-4889(94)00233-5
Ca2+/Mg(2+)-dependent endonuclease activation is an early event in VP-16-induced apoptosis of human breast cancer MCF7 cells in vitro.
I. Sokolova (1995)
10.1056/NEJM198908173210702
A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.
E. Crawford (1989)
Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma.
A. Howlett (1995)
Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.
N. Kyprianou (1991)
10.1002/PROS.2990130203
Activation of a Ca2+−Mg2+‐dependent endonuclease as an early event in castration‐induced prostatic cell death
N. Kyprianou (1988)
10.1677/JME.0.0140391
Vitamin D derivatives in combination with 9-cis retinoic acid promote active cell death in breast cancer cells.
S. James (1995)
10.1038/371346A0
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
Y. Lazebnik (1994)
bcl-xs gene therapy induces apoptosis of human mammary tumors in nude mice.
M. W. Ealovega (1996)
10.1002/J.1939-4640.1992.TB00337.X
Androgen regulation of programmed death of normal and malignant prostatic cells.
J. Isaacs (1992)
10.1210/ENDO-122-2-552
Activation of programmed cell death in the rat ventral prostate after castration.
N. Kyprianou (1988)
10.1016/0022-4731(72)90086-6
Structural recognitions in the interactions of androgens and receptor proteins and in their association with nuclear acceptor components.
S. Liao (1972)
10.1210/MEND-1-3-216
Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines.
N. Davidson (1987)
10.1002/PROS.2990040405
Prostatic structure and function in relation to the etiology of prostatic cancer
J. Isaacs (1983)
10.1093/JNCI/85.16.1327
Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies.
J. Baselga (1993)
10.1093/JNCI/82.1.4
What is the evidence that tumors are angiogenesis dependent?
J. Folkman (1990)
10.3322/CANJCLIN.46.1.5
Cancer statistics, 1996
S. Parker (1996)
Programmed cell death during regression of PC-82 human prostate cancer following androgen ablation.
N. Kyprianou (1990)
10.1042/BJ1170017
Concentrations of putrescine and polyamines and their enzymic synthesis during androgen-induced prostatic growth.
A. Pegg (1970)
10.1139/O94-072
Induction of apoptosis in breast cancer cells in response to vitamin D and antiestrogens.
J. Welsh (1994)
Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifen-induced apoptosis in human MCF-7 breast cancer cells.
R. Kumar (1996)
Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis.
W. May (1994)
Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps.
J. Lytton (1991)
Semenogelin, the predominant protein in human semen. Primary structure and identification of closely related proteins in the male accessory sex glands and on the spermatozoa.
H. Lilja (1989)
10.1038/bjc.1981.168
Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast.
D. J. Ferguson (1981)
10.1002/PROS.2990250604
Proliferation‐dependent vs. independent programmed cell death of prostatic cancer cells involves distinct gene regulation
Y. Furuya (1994)
Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
E. Pizer (1996)
Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway.
M. V. Blagosklonny (1996)
10.1016/0959-8049(94)00262-4
Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells.
M. C. Pagliacci (1994)
10.1016/0005-2787(73)90336-5
The effects of testosterone, 5 -dihydrotestosterone and adenosine 3',5'-monophosphate on cell proliferation and differentiation in rat prostate.
B. Lesser (1973)
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
S. Kaufmann (1993)
10.1016/S0022-5347(17)35032-2
Demonstration of a rational strategy for human prostate cancer gene therapy.
M. Sanda (1994)
20-epi-vitamin D3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines.
E. Elstner (1995)
10.1073/PNAS.83.10.3166
Human prostate-specific antigen: structural and functional similarity with serine proteases.
K. Watt (1986)
10.1111/J.1432-1033.1990.TB19466.X
Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.
A. Christensson (1990)
10.1093/JNCI/88.5.279
Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells.
Y. Kang (1996)
10.1038/bjc.1994.22
bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer.
R. Leek (1994)
10.1038/376037A0
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
D. Nicholson (1995)
Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.
V. Ponnathpur (1995)
The role of calcium, pH, and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin.
Y. Furuya (1994)
10.1172/JCI117871
Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin.
X. Wu (1995)
Paclitaxel induces programmed cell death in MDA-MB-468 human breast cancer cells.
D. McCloskey (1996)
10.1093/JNCI/85.17.1412
Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro.
A. Wärri (1993)
10.1093/OXFORDJOURNALS.ANNONC.A059158
Multiple expression patterns of biopathological markers in primary invasive breast carcinoma: a useful tool for elucidating its biological behaviour.
C. Ceccarelli (1995)
10.1073/PNAS.87.7.2466
Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase.
O. Thastrup (1990)
10.1073/PNAS.91.14.6379
Fatty acid synthesis: a potential selective target for antineoplastic therapy.
F. Kuhajda (1994)
10.1210/ENDO.133.6.8243289
Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation.
Y. Furuya (1993)
Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.
C. Teixeira (1995)
Programmed death of nonproliferating androgen-independent prostatic cancer cells.
P. Martikainen (1991)
10.1016/0003-9861(68)90319-6
Polymerization of deoxyribonucleotides in relation to androgen-induced prostatic growth.
D. Coffey (1968)
10.1210/MEND.6.12.1491693
Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin.
G. Yan (1992)
10.1038/362847A0
p53 is required for radiation-induced apoptosis in mouse thymocytes
S. Lowe (1993)
10.1042/BJ2600697
Polyamine depletion is associated with altered chromatin structure in HeLa cells.
R. Snyder (1989)
10.1002/PROS.2990110106
Quantal relationship between prostatic dihydrotestosterone and prostatic cell content: Critical threshold concept
N. Kyprianou (1987)
10.1016/0022-4731(88)90084-2
Quantitative assessment of endogenous testicular and adrenal sex steroids and of steroid metabolizing enzymes in untreated human prostatic cancerous tissue.
H. Klein (1988)
Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer.
H. Yu (1995)
Apoptotic cell death and tissue remodelling during mouse mammary gland involution.
R. Strange (1992)
10.1002/PROS.2990050510
Antagonistic effect of androgen on prostatic cell death
J. Isaacs (1984)
10.1093/CLINCHEM/37.9.1618
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.
H. Lilja (1991)
Implication of cell kinetic changes during the progression of human prostatic cancer.
R. Berges (1995)
Antiangiogenic effects of the quinoline-3-carboxamide linomide.
J. Vukanović (1993)
10.1002/PROS.2990230208
Castration‐induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice
W. V. van Weerden (1993)
10.1002/PROS.2990170302
Role of calcium in the programmed death of rat prostatic glandular cells
P. Martikainen (1990)
10.1002/PROS.2990080105
Androgen‐repressed messages in the rat ventral prostate
M. Montpetit (1986)
Identification of glutathione S-transferase Yb1 mRNA as the androgen-repressed mRNA by cDNA cloning and sequence analysis.
C. Chang (1987)
10.1210/ENDO.136.5.7720636
Androgen ablation-induced programmed death of prostatic glandular cells does not involve recruitment into a defective cell cycle or p53 induction.
Y. Furuya (1995)
Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers.
J. Vukanović (1995)
10.1002/AJA.1001850104
Cell death by apoptosis during involution of the lactating breast in mice and rats.
N. Walker (1989)
10.1002/PROS.2990110406
Cell proliferation studies in the rat prostate: II. The effects of castration and androgen‐induced regeneration upon basal and secretory cell proliferation
G. Evans (1987)
10.1210/MEND-2-7-650
Cascade induction of c-fos, c-myc, and heat shock 70K transcripts during regression of the rat ventral prostate gland.
R. Buttyan (1988)
10.1016/0165-6147(85)90081-1
Natural Products and Drug Development: edited by P. Krogsgaard-Larsen, S. Brøgger Christensen and Helmer Kofod, Munksgaard, 1984. Dkr 375.00 (559 pages) ISBN 87 16 09563 4
J. D. Phillipson (1985)
Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline.
S. Fan (1995)
10.1016/S0344-0338(81)80124-0
Die Regression der Rattenprostata nach Kastration
R. Stiens (1981)
The antitumor effects of the quinoline-3-carboxamide linomide on Dunning R-3327 rat prostatic cancers.
T. Ichikawa (1992)
10.1111/J.1432-1033.1994.00311.X
Axial coordination and reduction potentials of the sixteen hemes in high-molecular-mass cytochrome c from Desulfovibrio vulgaris (Hildenborough).
M. Verhagen (1994)
10.1073/PNAS.90.19.8910
Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation.
R. Berges (1993)
10.1093/CLINCHEM/42.3.361
Detection of prostate-specific antigen mRNA and protein in breast tumors.
N. Zarghami (1996)
10.1002/PROS.2990130204
Calcium channel antagonists delay regression of androgen‐dependent tissues and suppress gene activity associated with cell death
J. Connor (1988)
Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells.
A. Martí (1994)
10.1002/PROS.2990100405
Biological significance of measurable androgen levels in the rat ventral prostate following castration
N. Kyprianou (1987)
10.1089/HUM.1995.6.4-395
Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice.
L. Lesoon-Wood (1995)
Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells.
S. Bardon (1987)
Programmed cell death in an estrogen-independent human breast cancer cell line, MDA-MB-468.
D. Armstrong (1992)
Inhibition of breast cancer cell growth by combined treatment with vitamin D3 analogues and tamoxifen.
T. Vink-van Wijngaarden (1994)
10.1016/0022-4731(79)90090-6
A comparative study of binding, metabolism and endogenous levels of androgens in normal, hyperplastic and carcinomatous human prostate.
M. Krieg (1979)
Evidence for early induction of calmodulin gene expression in lymphocytes undergoing glucocorticoid-mediated apoptosis.
D. Dowd (1991)
Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7.
T. Wang (1995)
10.7326/0003-4819-89-1-107
Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review.
S. Shackney (1978)
10.1002/PROS.2990070106
Cellular response to androgen depletion and repletion in the rat ventral prostate: Autoradiography and morphometric analysis
Hugh F. English (1985)
10.1139/O94-074
The role of growth factors in the suppression of active cell death in the prostate: an hypothesis.
R. Guenette (1994)
Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells.
D. Armstrong (1994)
10.1016/0014-5793(87)80430-1
Induction and activation of tissue transglutaminase during programmed cell death
L. Fesus (1987)
10.1007/978-1-4613-1259-8
Mammary Tumor Cell Cycle, Differentiation, and Metastasis
R. Dickson (1996)
10.1016/0014-5793(93)80416-R
Derivatives of thapsigargin as probes of its binding site on endoplasmic reticulum Ca2+ ATPase
S. Christensen (1993)
10.1210/MEND-3-10-1515
Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death
N. Kyprianou (1989)
10.1038/343170A0
Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis
J. Savill (1990)
10.1210/ENDO-123-4-2124
Identification of a cellular receptor for transforming growth factor-beta in rat ventral prostate and its negative regulation by androgens.
N. Kyprianou (1988)
10.1016/0005-2787(71)90693-9
Biochemical characterization of prostatic nuclei. I. Androgen-induced changes in nuclear proteins.
L. Chung (1971)
10.1016/0006-291X(85)90131-7
MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF.
J. Filmus (1985)
10.1002/PROS.2990150304
Relationship between DNA fragmentation and apoptosis in the programmed cell death in the rat prostate following castration
H. English (1989)
10.1002/ANA.410210402
Calcium channels and calcium channel antagonists
D. Greenberg (1987)
10.1016/0092-8674(95)90541-3
Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
M. Tewari (1995)
10.1002/IJC.2910610413
MCF‐7 human mammary adenocarcinoma cell death in vitro in response to hormone‐withdrawal and dna damage
J. Wilson (1995)
Hormonally responsive versus unresponsive progression of prostatic cancer to antiandrogen therapy as studied with the Dunning R-3327-AT and -G rat adenocarcinomas.
J. Isaacs (1982)
10.1126/science.7531366
Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
N. Boudreau (1995)
Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells.
S. F. Sells (1994)
10.1128/MCB.9.8.3473
Induction of the TRPM-2 gene in cells undergoing programmed death.
R. Buttyan (1989)
The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro.
N. Bruchovsky (1968)
10.1111/J.1432-1033.1994.TB20055.X
Cathepsin B, a cysteine protease implicated in metastatic progression, is also expressed during regression of the rat prostate and mammary glands.
R. Guenette (1994)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar